Financials
- Market Capitalization 3.73 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry 生物工学
総売上高
当期純利益
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1508 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 33.31 USD | +0.09% | -9.95% | +6.83% | -8.16% | 3.89 B USD | ||
| 1534 | CPRX Catalyst Pharmaceuticals, Inc. - Common Stock | 31.49 USD | +0.03% | 0.00% | +0.41% | +48.47% | 3.85 B USD | ||
| 1562 | GPCR Structure Therapeutics Inc - American Depositary Shares | 50.56 USD | -2.09% | -10.72% | +17.58% | +89.08% | 3.59 B USD | ||
| 1566 | DNLI Denali Therapeutics Inc. - Common Stock | 22.65 USD | -14.46% | -13.91% | +3.61% | +40.07% | 3.59 B USD |